ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,858Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 2588

$1.43M Total Retail Price of All Prescriptions

Rank: 29 out of 2588

694 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 694 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

29% of this provider’s 694 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 21,053 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LEVOTHYROXINE SODIUM 1,238 1,042 1 2
HYDROCODONE-ACETAMINOPHEN 1,175 562 S3 2 7
METOPROLOL TARTRATE 1,040 835 3 9
AMLODIPINE BESYLATE 895 759 4 4
LISINOPRIL 854 725 5 3
OMEPRAZOLE 676 561 6 6
GABAPENTIN 634 395 7 18
METFORMIN HCL 631 474 8 8
SIMVASTATIN 622 496 9 1
ISOSORBIDE MONONITRATE ER 574 505 10 49
FUROSEMIDE 572 507 11 5
RANITIDINE HCL 449 259 12 37
WARFARIN SODIUM 443 391 13 10
METOPROLOL SUCCINATE 373 263 14 12
ATORVASTATIN CALCIUM 361 327 15 11
CITALOPRAM HBR 358 259 16 27
CLOPIDOGREL 356 327 17 30
NEXIUM 332 239 18 41
PANTOPRAZOLE SODIUM 331 275 19 28
DOXEPIN HCL 321 189 20 281
DICLOFENAC SODIUM 314 236 21 124
LOVASTATIN 311 263 22 34
SERTRALINE HCL 302 277 23 26
ALLOPURINOL 293 250 24 33
CARVEDILOL 283 238 25 20
PLAVIX 282 250 26 43
DONEPEZIL HCL 275 275 27 22
CYMBALTA 264 182 28 70
NAMENDA 260 248 29 32
POTASSIUM CHLORIDE 249 217 30 15
DOXAZOSIN MESYLATE 243 233 31 96
BENAZEPRIL HCL 235 178 32 84
DIGOXIN 233 210 33 38
FENOFIBRATE 232 172 34 64
HYDROCHLOROTHIAZIDE 207 158 35 13
CRESTOR 196 129 36 25
MELOXICAM 195 131 37 51
ZOLPIDEM TARTRATE 190 156 38 24
TRAMADOL HCL 180 136 39 19
SPIRONOLACTONE 180 148 39 58
TAMSULOSIN HCL 170 141 41 23
FLUOXETINE HCL 159 74 42 92
NAPROXEN 153 59 43 95
FENTANYL 153 132 S2 43 78
FLUTICASONE PROPIONATE 152 99 45 40
PRAVASTATIN SODIUM 152 102 45 16
LOSARTAN POTASSIUM 151 97 47 17
GLIMEPIRIDE 145 103 48 39
CARBIDOPA-LEVODOPA 145 117 48 83
JANUVIA 140 102 50 60
LOSARTAN-HYDROCHLOROTHIAZIDE 135 105 51 66
SPIRIVA 134 105 52 56
AZITHROMYCIN 134 93 52 45
BUPROPION HCL SR 132 34 54 246
MIRTAZAPINE 132 115 54 63
TRAZODONE HCL 127 82 56 61
DILTIAZEM ER 127 123 56 150
AMLODIPINE BESYLATE-BENAZEPRIL 127 116 56 76
ESCITALOPRAM OXALATE 126 61 59 68
GEMFIBROZIL 121 109 60 123
LYRICA 121 72 60 100
HYDRALAZINE HCL 113 82 62 53
ATENOLOL 112 87 63 14
POLYETHYLENE GLYCOL 3350 108 100 64 55
PREDNISONE 106 88 65 42
LISINOPRIL-HYDROCHLOROTHIAZIDE 99 60 66 35
CIPROFLOXACIN HCL 98 73 67 82
ENALAPRIL MALEATE 98 57 67 31
SINGULAIR 97 47 69 94
SYMBICORT 97 32 69 129
AMITRIPTYLINE HCL 96 75 R 71 91
DIOVAN 93 81 72 29
ZETIA 90 54 73 69
CYCLOBENZAPRINE HCL 89 32 R 74 87
LEVOFLOXACIN 88 66 75 77
PROAIR HFA 86 40 76 50
LANTUS 83 66 77 47
DILTIAZEM 24HR CD 83 72 77 98
NORTRIPTYLINE HCL 81 73 79 237
MUPIROCIN 81 59 79 235
ACETAMINOPHEN-CODEINE 80 43 S3 81 80
GLIPIZIDE 78 68 82 44
TRICOR 78 55 82 122
ADVAIR DISKUS 78 72 82 48
JANUMET 77 69 85 211
FELODIPINE ER 76 63 86 108
BENICAR 74 74 87 143
RISPERIDONE 73 42 88 57
GLYBURIDE 72 56 R 89 65
CELEBREX 71 70 90 99
CLONIDINE HCL 67 34 91 54
INSULIN SYRINGE 66 35 92 81
MONTELUKAST SODIUM 62 29 93 153
COLESTIPOL HCL 62 58 93 479
QUETIAPINE FUMARATE 60 55 95 74
SULFAMETHOXAZOLE-TRIMETHOPRIM 60 47 95 127
TRIAMCINOLONE ACETONIDE 59 40 97 106
KLOR-CON M20 59 39 97 52
SEROQUEL XR 58 56 99 268
BYSTOLIC 57 52 100 110
ROPINIROLE HCL 56 40 101 113
ALENDRONATE SODIUM 55 51 102 21
TOPIRAMATE 55 13 102 167
OXYCODONE-ACETAMINOPHEN 54 48 S2 104 218
RANEXA 54 43 104 395
LEXAPRO 53 27 106 182
LANTUS SOLOSTAR 52 43 107 93
OXYBUTYNIN CHLORIDE 50 46 108 132
PEN NEEDLE 50 39 108 112
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 1, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.